Skip to main content
. 2022 Aug 22;17:99. doi: 10.1186/s13020-022-00654-z

Table 6.

Changes in healthy (balanced), sub-healthy, and disease (unbalanced) BCs in participants within corresponding subgroups upon CM treatment and at follow-up

(A) Participants with particular CM syndromes
% among group Baseline (V1) After CM treatment (V4) After CM treatment (V7) Follow-up (V8)
Disease 80.77 82.93 81.54 82
Sub-healthy 8.65 3.66 7.69 8
Healthy 10.58 13.41 10.77 10
(B) Participants without particular CM syndromes
% among group Baseline (V1) After CM treatment (V4) After CM treatment (V7) Follow-up (V8)
Disease 78.95 65.96 59.09 68.85
Sub-healthy 18.42 17.02 18.18 16.39
Healthy 2.63 17.02 22.73 14.75